1. The TrueTear Intranasal Tear Neurostimulator uses electrical stimulation to temporarily increase tear production in adult patients with dry eye.
2. The cholesterol drug Praluent may now be administered in a once-monthly dose form.
3. Brineura is the first treatment for a specific form of Batten disease, an extremely rare pediatric neurosystem disorder.
4. Stivarga can now be used as a second-line treatment for hepatocellular carcinoma, the most common type of liver cancer.
More articles on supply chain:
Corporate Whistleblower Center encourages pharma employees to report unsanitary drug plant conditions
7 must-reads for supply chain leaders this week
Dem. Senators pen letter to Dr. Scott Gottlieb on FDA hiring freeze
